greeksoup/ stock research
Stock research / United States / AMRX / Documents

Amneal Pharmaceuticals, Inc. documents

Amneal Pharmaceuticals (AMRX) annual report: the 10-K filed 27 February 2026 for the year ended 31 December 2025. Proxy statement (DEF 14A) filed 25 March 2026; latest 10-Q filed 6 August 2026 for the quarter ended 30 June 2026. Each links to the document on EDGAR, with 5 earnings press releases.

Earnings press releases (exhibit 99 to each results 8-K)

FiledDocumentOpenWhere
30 July 2026Results press release, exhibit 99 to the 8-K filed 30 July 2026The releaseEDGAR folder
7 May 2026Results press release, exhibit 99 to the 8-K filed 7 May 2026The releaseEDGAR folder
22 April 2026Results press release, exhibit 99 to the 8-K filed 22 April 2026The releaseEDGAR folder
27 February 2026Results press release, exhibit 99 to the 8-K filed 27 February 2026The releaseEDGAR folder
30 October 2025Results press release, exhibit 99 to the 8-K filed 30 October 2025The releaseEDGAR folder

Annual reports (10-K)

FiledDocumentOpenWhere
27 February 202610-K, period ended 31 December 2025The documentEDGAR folder

Quarterly reports (10-Q)

FiledDocumentOpenWhere
6 August 202610-Q, period ended 30 June 2026The documentEDGAR folder
7 May 202610-Q, period ended 31 March 2026The documentEDGAR folder
6 November 202510-Q, period ended 30 September 2025The documentEDGAR folder

Proxy statements

FiledDocumentOpenWhere
25 March 2026DEF 14A, period ended 6 May 2026The documentEDGAR folder